Ex-CEO Admits Securities Fraud In Fake COVID Test Case
By Mark Payne · December 8, 2023, 7:16 PM EST
A former biotech CEO pled guilty in D.C. federal court Thursday to charges of securities fraud, wire fraud and obstruction after he concocted a scheme to defraud investors by falsely telling...
To view the full article, register now.